OMX Nordic 40
2.523,26
PKT
-13,16
PKT
-0,52
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
18.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.03.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
11.03.19 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
05.03.19 | Novo Nordisk Outperform | Bernstein Research | |
05.03.19 | AstraZeneca buy | Deutsche Bank AG | |
05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.03.19 | Novo Nordisk Reduce | HSBC | |
04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.03.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
04.03.19 | Nokia Neutral | Goldman Sachs Group Inc. | |
04.03.19 | Ericsson (Telefon L.M.Ericsson) (B) buy | Goldman Sachs Group Inc. | |
01.03.19 | Nokia buy | Kepler Cheuvreux | |
01.03.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
28.02.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
28.02.19 | AstraZeneca Reduce | HSBC | |
28.02.19 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
28.02.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
28.02.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
27.02.19 | Nokia Neutral | Goldman Sachs Group Inc. | |
26.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
26.02.19 | AstraZeneca buy | Deutsche Bank AG | |
26.02.19 | AstraZeneca overweight | Barclays Capital | |
26.02.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
25.02.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
25.02.19 | AstraZeneca overweight | Barclays Capital | |
25.02.19 | Nokia Outperform | Credit Suisse Group | |
25.02.19 | Nokia buy | UBS AG | |
20.02.19 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Kepler Cheuvreux | |
18.02.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
18.02.19 | AstraZeneca buy | Deutsche Bank AG | |
15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
14.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
14.02.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
14.02.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
13.02.19 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
12.02.19 | Volvo (B) Sell | UBS AG | |
11.02.19 | Novo Nordisk Reduce | HSBC | |
08.02.19 | Nokia buy | Deutsche Bank AG | |
06.02.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
05.02.19 | Volvo (B) buy | Jefferies & Company Inc. |